Delivery Order SPE2DB25D2207-SPE2DB25FQRNN

The Defense Logistics Agency awarded a $3,292.56 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors with an ultimate completion date of August 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare systems worldwide.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies through its DLA contracts, including brand-name and generic medications, specialty treatments, and medical devices. The Zepbound order represents a routine delivery under the broader pharmaceutical prime vendor agreement, supporting the Defense Health Agency and other federal healthcare entities. AmerisourceBergen's demonstrated capability to compete successfully for federal contracts and manage significant procurement volumes positions it as a key supplier within the Department of Defense's medical supply chain.